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1. Introduction 
P.N. Magee (London, U.K.). It is now established 
that many types of cancer in man are caused by 
environmental factors and that these factors include 
carcinogenic chemicals. Since the pioneering work of 
Pott, Yamagiwa and Ichikawa, and Kennaway, a large 
number of pure chemicals has been shown to cause 
cancer in experimental animals, often at very low dose 
levels. Certain chemical carcinogens are known which 
are active after only one dose, the tumours becoming 
clinically apparent months later. An obvious feature 
of any list of chemical carcinogens is their widely dif- 
fering chemical structures and this has led to the reali- 
zation that many chemicals are not carcinogenic 
themselves but only become so after metabolic con- 
version in the body to more biologically active forms. 
In the terminology of J.A. and E.C. Miller the parent 
compound is a precarcinogen, the metabolites with 
greater carcinogenic potency are proximate carcinogens 
and the final active molecular species is the ultimate 
carcinogen. There are, of course, some chemicals 
which do not require metabolic activation for car- 
cinogenic action. It is widely assumed that the reactive 
ultimate carcinogen, which is usually an electrophile, 
reacts with nucleophilic centres in the cell and thus 
induces the change to malignancy. It is further 
assumed that the crucial cellular interaction for 
carcinogenesis is between the ultimate carcinogen 
and a nucleic acid or a protein or both. There is no 
general agreement which of these macromolecules is 
the crucial cellular target. Reaction with DNA could 
produce mutant somatic cells, some of which might 
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have the required properties for malignant growth and 
which could escape the postulated immunological 
surveillance mechanisms which are concerned with 
the elimination of cancer cells from the body. If DNA 
is the primary target for carcinogenesis, mechanisms 
by which the initial damage could be repaired might 
be of great importance in determining whether trans- 
formation occurred or not. Transfer RNA has also 
been suggested as the primary target in carcinogenesis 
and aberrant tRNA methylation implicated in its 
modification. Proteins were the first targets of 
chemical carcinogens to be reported and certain 
cytoplasmic proteins of the ‘h’ and similar types are 
under continued study in several aboratories. 
There is great current interest in viral carcinogenesis 
and possible inter-relationships with chemical car- 
cinogenesis are being explored. There is evidence that 
carcinogenic chemicals, like X-rays, can activate 
oncogenic leukaemogenic viruses but it is not 
established whether such a process occurs in the induc- 
tion of all types of tumour. It has been postulated that 
the cells of most or all vertebrate species contain 
genomes of RNA tumour viruses that are vertically 
transmitted from parent to offspring. This hypothesis 
suggests that chemical carcinogens may act directly 
on oncogenic information contained in the viral 
genome, the so-called oncogene. 
Aspects of these ideas on the mechanism of 
chemical carcinogenesis were discussed at the Course 
and are briefly reported below. 
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2. Metabolism of chemical carcinogens and interaction 
with cellular macromolecules 
2.1. First Session. (Chairman: P.N. Magee, London, 
U.K.) 
The first part of this session was concerned with 
carcinogenesis by nitroso compounds and was opened 
by R. Preussmann (Heidelberg, W. Germany) who 
discussed structure-activity relationships of these and 
related carcinogens including hydrazo-, azo and 
azoxy-alkanes and I-aryl-3-mono- and dialkyl triazenes, 
emphasizing their remarkable organ specificity in 
experimental animals. Malignant tumours have been 
induced in liver, lungs, kidney, urinary bladder, 
oesophagus, stomach, intestine, nasal cavity, brain, 
spinal cord and peripheral nerves of rats, the target 
organ depending on the compound used. In all the 
groups of compounds small changes in the chemical 
structure often lead to striking differences in the 
organs in which tumours are induced. Thus the organ 
specificity islargely governed by the chemical struc- 
ture of the carcinogen and to some extent also by the 
animal species, the route of administration and the 
doses used. Many of these carcinogens are active after 
single doses. Nitrosamines, hydrazo-, azo- and azoxy- 
alkanes, as well as I-aryl-3,3_dialkyltriazenes require 
metabolic activation to form the proximate and ulti- 
mate carcinogenic intermediates while nitrosamides, 
such as N-nitroseN-methylurea and 1-aryl-3-mono 
alkyltriazenes are activated by hydrolytic processes 
without involvement of enzymes. Alkylation in vivo 
of nucleic acids and proteins occurs after administra- 
tion of these carcinogens and the probable ultimate 
carcinogen is an alkylating agent. Some of these com- 
pounds, especially those with ethyl groups, have 
powerful transplacental carcinogenic effects, leading 
to a high incidence (up to 100%) of tumours in the 
offspring of treated mother rats. Such tumours usually 
appear at an early age and are predominantly located 
in the nervous system. 
P.F. Swunn (London, U.K.) discussed the useful- 
ness of N-nitroso compounds in studies designed to 
elucidate the mechanism of the induction of cancer, 
underlining their chemical simplicity and high 
carcinogenic activity. He described experiments on the 
alkylation of nucleic acids in vivo by the nitroso 
compounds which supported the view derived from 
structure-activity relationships (see above) that these 
carcinogens owe their carcinogenic activity to the 
production of alkylating intermediates during their 
breakdown in the animal. The critical cellular target 
for this alkylation is not known and the problems of 
identifying it were discussed. Some criteria for an 
experimental approach to these problems were pro- 
posed based on observed differences in carcinogenic 
behaviour of different alkylating agents. The induc- 
tion of kidney tumours in the rat by single doses of 
several alkylating carcinogens was suggested as a model 
for study since dimethylnitrosamine and N-nitroso- 
methylurea were both active under these conditions 
but methyl methanesulphonate was not. Since the 
latter compound gave rise to a similar degree of 
methylation of kidney nucleic acids in vivo the dif- 
ference in carcinogenic activity provided a.potential 
means for distinguishing between biochemical effects 
which were essential or inessential for the induction 
of the tumours. In contrast to the behaviour of these 
methylating compounds, the corresponding ethyl 
derivatives, diethylnitrosamine, N-ethylnitrosourea 
and ethyl methanesulphonate all induced kidney 
tumours in the rat. 
C. Heidelberger (Madison, Wise., USA) then 
changed the topic to polycyclic hydrocarbons and 
carcinogenesis in vitro using cell cultures of fibroblas- 
tic lines derived from adult C3H mouse prostate. 
After describing criteria for transformation in vitro 
he showed that this phenomenon was unrelated to 
toxicity. Single individual cells could be transformed 
with high efficiency and different colonies of trans- 
formed cells did not show common surface antigens. 
In this system there was strong evidence that the 
polycyclic hydrocarbons required metabolic activation 
to produce transformation. Experiments had shown 
that K-region epoxides were formed which were more 
active than the parent polycyclic hydrocarbons in 
producing malignant transformation and were prob- 
ably proximate carcinogenic derivatives of the hydro- 
carbons. The epoxides reacted with DNA, RNA and 
protein of the cells to a greater extent than the parent 
hydrocarbons or other derivatives including phenols 
and cis and tram dihydrodiols. Emphasis was placed 
on binding of the epoxides to ‘h’ proteins which was 
thought to play some role in chemical oncogenesis. 
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2.2. Second Session. (Chairman: E. Hecker, Heidel- 
berg, W. Germany) 
P. Brookes (London, U.K.) reviewed earlier work 
on the binding of carcinogenic polycyclic hydro- 
carbons to macromolecules of mouse skin emphasising 
the necessity of metabolic activation and the signifi- 
cance of DNA binding. Experiments with rodent cells 
in tissue culture had advantages for quantitation of 
data on extents of binding. Both carcinogenic and 
non-carcinogenic compounds were metabolised but 
covalent binding to nucleic acids was only significant 
with the carcinogens. Human embryo lung cells were 
able to metabolise polycyclic hydrocarbons to products 
which became bound to DNA. 
E. Kriek (The Netherlands) outlined previous work 
on the metabolism of the carcinogenic aromatic amine, 
2-acetylaminofluorene, discussing the role of the 
endoplasmic reticulum of the liver and the formation 
of derivatives which react with cellular macromole- 
cules. The first metabolic reaction is N-hydroxylation 
of the parent compound followed by formation of 
the N-sulphate ester. This ester is a highly reactive 
electrophile that attacks nucleophilic groups in the 
cell, the main site of action in the nucleic acids being 
the C-8 position of guanosine. The major part of the 
carcinogen bound to tRNA and rRNA in rat liver is 
acetylaminofluorene but about 70% of that bound to 
DNA is deacetylated. Another derivative of acetylamino- 
fluorene has been isolated from hydrolysates of DNA 
containing bound carcinogen but it has not yet been 
characterized. This minor reaction product was still 
detected in rat liver DNA two months after injection 
of N-hydroxy-acetylaminofluorene but the carcinogen 
bound on the C-8 position of guanosine was removed 
more rapidly with a biological half-life of approxima- 
tely 7 days. 
B. Ketterer (London, U.K.) returned to the binding 
of chemical carcinogens to cellular proteins with 
reference to the azo dye, pdimethylaminoazobenzene. 
After injection into animals this compound is bound 
to a soluble protein in the liver cell cytoplasm which 
is identical with the protein known as ligandin which 
also binds steroids, bilirubin and various exogenous 
anions. Most of these compounds are not bound 
covalently but the binding with the azo dye is 
covalent. Other compounds which bind to ligandin 
include haematin and stilboestrol. Ligandin is a major 
protein component of liver cell sap and can be induced 
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with agents such as phenobarbitone and DDT. It also 
occurs in kidney intestinal mucosa, urinary bladder, 
lung and skin. The function of this protein is not yet 
established. It may not play a direct role in carcino- 
genesis but may have a transport function or play a part 
in cellular control mechanisms. 
2.3. Third Session. (Chairman: D.B. Ludlum) 
RD. Lawley (London, U.K.) developed the dis- 
cussion of the relation of alkylation to carcinogenesis 
further, suggesting that the initiation stage of carcino 
genesis may be a somatic mutation and that relation- 
ships between alkylation mutagenesis and reactivity 
of alkylating agents may therefore apply to carcino- 
genesis. Several sites in nucleic acids are now known 
to be reactive towards alkylating agents, including 
N-l, N-3 and N-7 of adenine; N-3, N-7 and O-6 of 
guanine and N-3 of cytosine. There are differences in 
the relative reactivities of these sites for different 
alkylating agents which can be correlated with their 
classification, following Ingold, into S,l and S,2 
types. However, the simple prediction that S,l agents 
should react to a greater extent at the sites of lower 
nucleophilicity than should the $2 agents is not 
confirmed experimentally. Recent work by Loveless 
and by Ehrenberg and their colleagues has suggested 
that S, 1 character is positively correlated with 
mutagenic activity. It seems possible, therefore, that a 
further correlation between the spectrum of reaction 
products in DNA and induced mutation will be dis- 
cernible. The suggestion that alkylation on the O-6 
position of guanine may be important in mutagenesis 
is attractive since it gives rise to a mispairing base and 
also fits the correlation between S,l reaction and 
mutation. Ludlum has reported that 3-methylcytosine 
in polynucleotide templates can cause miscoding in 
vitro and has proposed this as a promutagenic group. 
The differing capacities of nitroso compounds and 
methyl methanesulphonate to induce kidney tumours 
in the rat reported by Swarm and Magee (see above) 
also supports a relationship between carcinogenesis 
and S, 1 reactivity. It seems likely, however, that a 
gradation of both the chemical and biological proper- 
ties of these agents wiII be found rather than a clear- 
cut distinction between two types. 
V. Wunderlich (Berlin-Buch, G.D.R.) discussed the 
possible role of mitochondrial DNA in carcinogenesis. 
After reviewing some earlier findings suggesting in- 
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volvement of mitochondria in carcinogenesis uch as 
respiratory impairment, loss of swelling-contraction 
functions, etc., he concluded that these were probably 
secondary events and suggested that changes in mite 
chondrial DNA might be more relevant. So far, how- 
ever, physicochemical studies of DNA from tumours 
have not revealed any specific changes. Studies were 
reported on the reaction of liver mitochondrial DNA 
with N-nitrosomethylurea or dimethylnitrosamine 
after these carcinogens were administered to rats and 
hamsters. Mitochondrial DNA was more highly 
methylated than nuclear DNA, mitochondrial RNA 
and mitochondrial protein. These results were con- 
sidered to support the hypothesis that mutations at 
the mitochondrial level may be particularly involved 
in carcinogenesis, as first proposed by Graffi. Since 
several nitroso compounds are known to mutate mito- 
chondria in microorganisms and plants, such organisms 
might provide useful models for study of interactions 
between chemical carcinogens and mitochondria. 
Mitochondrial DNA has advtitages over nuclear DNA 
for the study of the effects of chemical carcinogens 
on functional activities of DNA such as DNA synthesis, 
repair synthesis and transcription. Carcinogen induced 
changes in tertiary structure are readily measureable 
as changes in superhelix density. 
B.R. Rabin (London, U.K.) introduced a new topic 
by describing work exploring the mechanism of the 
inhibition of protein synthesis in rat liver by the 
powerful carcinogen aflatoxin. In the experimental 
system used the binding of ribosomes to the endo- 
plasmic reticulum was monitored by measuring the 
apparent activity of a membrane bound disulphide 
interchange enzyme, normally masked by bound ribo- 
somes. Oestradiol was shown to be necessary for the 
binding of ribosomes to the endoplasmic reticulum of 
male rats and testosterone for binding to female end@ 
plasmic reticulum. Aflatoxin, which appeared to act 
without metabolic activation, displaced ribosomes 
from the reticulum in an irreversible manner. Prior 
treatment with oestradiol protected the male endo 
plasmic reticulum and testosterone protected the 
female reticulum from degranulation by aflatoxin. 
Similar results were obtained with other carcinogens 
suggesting that interaction with steroid binding sites 
in the endoplasmic reticulum may be a common 
feature of such compounds. The possibility that these 
reactions might be used as a test for chemical carcino- 
gens was discussed. 
E. Hecker (Heidelberg, W. Germany) gave a concise 
survey of present ideas on initiation and promotion 
mechanisms in chemical carcinogenesis describing in 
detail the procedures used in his laboratory. A single 
initiating dose of 7,12-dimethylbenz [alanthracene 
(DMBA), 10 pmole, is administered to mice by 
stomach tube followed by twice weekly topical ap- 
plications of an active tumour promoting agent such 
as 12-O-tetradecanoylphorbol-13-acetate (TPA), 
0.02 pmole, to the skin of the back. This treatment 
yields 4 to 5 skin tumours per mouse within three 
months. In order to distinguish between specific 
carcinogenesis and non-specific biochemical changes, 
other groups of mice are given chemicals of the same 
type which lack initiating activity such as dibenz [a,c] - 
anthracene or promoting activity such as 4cll-phorbol- 
12,13-didecanoate (4cu-PDD). Experiments on the fate 
of radioactively labelled DMBA and TPA were described 
including investigation of their binding to nucleic 
acids and proteins of mouse skin. Since the active 
promoter was bound to skin proteins to the same 
extent as the inactive compound, it was concluded 
that covalent protein binding had nothing to do with 
promotion. Incorporation of labelled choline into 
lecithin of mouse skin was markedly stimulated by 
the active promoter but the inactive compound had 
no such effect. 
3. The possible role of nucleic acid methylases in 
carcinogenesis 
(Chairman: E. Borek, Denver, Colo., USA). The 
Chairman reviewed the current status of knowledge 
about the enzymes that modify tRNA with particular 
emphasis on the tRNA methyl transferases. He 
pointed out that these enzymes present in crude 
tissue extracts from tumours were aberrantly hyper- 
active when compared to enzymes from normal tissues 
and that several workers had reported an increased 
content of methylated bases to be present in tRNA 
of tumour tissues. Dr. Borek described the regulatory 
functions attributed to tRNA and stressed that even 
minor changes in tRNA structure could affect such 
regulatory functions. He, therefore, suggested that 
alteration of tRNA could modify animal cells in a 
manner at present hidden in the multiplicity of func- 
tions of tRNA but leading to tumour growth. 
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Dr. Borek stressed that the induction of a virus 
integrated within the genome of the cell might be the 
mechanism of chemical carcinogenesis and thought 
that the high frequency of ‘carcinogenesis’ of cells in 
tissue culture was more consistent with this idea than 
mechanisms involving mutation. He proposed that the 
only permanently and constantly altered macromole- 
cule in tumours is tRNA and noted that tRNA’s were 
altered in bacteria after lysogenic induction. Therefore, 
chemical carcinogenesis might be attributed to activa- 
tion of a virus leading to an altered tRNA possibly by 
the action of virus-specified tRNA methylases. 
VQMQ hf. Cradd~~k (Carshalton, U.K.) supported 
Dr. Borek’s suggestion by showing that during feeding 
of dimethylnitrosamine there was increased methyl- 
ation of liver tRNA in vivo and enhanced activity of 
tRNA methylases present in liver homogenates assayed 
in vitro. The increased methylation of tRNA was not 
due merely to increased nucleic acid synthesis as the 
amounts of the N’substituted guanines produced 
were increased to a greater extent than the other 
methylated bases. In contrast, the methylation of 
DNA corresponded to that of controls when the rate 
of DNA synthesis was taken into account. Increased 
methylation of tRNA was not seen in regenerating 
liver or in liver from animals treated with nitrosamines 
which became cirrhotic rather than malignant. Dr. 
Craddock thought it unlikely that there was any direct 
connection between alkylation of tRNA caused by 
reaction with alkylating carcinogens and the altered 
activity of tRNA methylases (both Dr. Craddock and 
Dr. Pegg emphasized the difference in the methylated 
bases produced by the different pathways). Dr. 
Craddock postulated that reaction of the carcinogen 
with the chromatin, possibly by producing a mutation- 
like change, was responsible for the carcinogenesis and 
that the altered tRNA methylase activity is one of 
the ways in which the alteration in the genome 
expresses itself. 
AX Pegg (London, U.K.) described studies on the 
specificity of tRNA methyltransferases from mouse 
colon and colonic tumours induced by administration 
of dimethylnitrosamine. Purified tRNA’s from yeast 
and bacteria were utilised as substrates for methylation 
and the nucleotide sequences methylated identified 
by standard methods for sequencing RNA. Although 
the tumour cell extracts catalysed methylation of these 
tRNA’s to a greater extent and at a faster rate than 
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extracts from normal cells, there were no differences 
in the sites methylated within the tRNA’s tested as 
substrates. Dr. Pegg concluded that an increased 
extent of methylation of tRNA in vitro by crude 
tissue extracts from tumours did not necessarily 
represent a change in specificity of the tRNA methyl- 
transferases and therefore that further analysis of 
tRNA sequences was required before the conclusion 
could be drawn that tRNA methylases from tumour 
could methylate tRNA molecules at sites not methyl- 
ated by enzymes from control tissues. 
Dr. Pegg also described some studies on the ethyl- 
ation of nucleic acids following the administration to 
rats of a single dose of ethionine. Analysis of the 
ethylated bases in tRNA and direct experiments in 
vitro with liver tRNA methyltransferases were con- 
sistent with the view that ethylation occurred by the 
action of these enzymes utilising S-adenosyl-L- 
ethionine as an alkyl donor. However, some evidence 
that a minor proportion of the ethylation of tRNA 
occurred by another pathway was obtained and a 
small amount of ethylation of DNA producing 
7-ethylguanine was also noted. Dr. Borek thought that 
this small amount of ethylation of DNA was insigni- 
ficant in carcinogenesis but Dr. Pegg and Dr. Swann 
pointed out that ethionine is not a potent carcinogen 
and must be fed at high doses for a considerable time 
before producing tumours and that since the degree 
of ethylation of DNA under conditions required to 
produce hepatomas was unknown the question of 
the significance of ethylation of DNA during 
carcinogenesis by ethionine was difficult to evaluate. 
4. Nucleic acid repair and its possible role in chemical 
carcinogenesis 
(Chairman: M.M. Elkind, Brookhaven, Corm., USA). 
B.S. Strauss (Chicago, Ill., USA) opened this session, 
pointing out the good correlation between the ability 
of compounds to induce cancer and their ability to 
induce mutation. Since mutagens must necessarily 
change nuclear DNA to produce their effect, it is 
often assumed that carcinogens must also interact 
with DNA and that the mechanisms of carcinogenesis 
and mutagenesis are similar. The discovery of cellular 
systems which can repair damage produced by muta- 
gens suggests that there may be some connection 
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between the ability to repair damage produced by a 
carcinogen and its carcinogenic activity. Repair of 
damage induced in bacteria by ultraviolet light (U.V.) 
was described in some detail, emphasising the impor- 
tance of analysis of UV-resistant mutants leading to 
the recognition of several different repair processes. 
The process of excision repair involves a series of steps 
including incision, excision, repair synthesis and 
joining. A second repair mechanism occurs after DNA 
synthesis (post replication repair) but its detailed 
mechanism is not understood. Other repair systems 
participating in recombination have been described. 
The most important evidence that repair, or more 
precisely lack of repair, is involved in carcinogenesis 
has been the observation that Xeroderma pigmen- 
tosum patients, who lack the incision enzyme, are 
very likely to develop tumours in parts of the body 
exposed to light. If there is a connection between 
carcinogenesis and repair it is most probably a negative 
one. Carcinogenesis might arise from the failure of the 
repair mechanisms to recognize and to remove a 
potentially carcinogenic lesion in DNA. 
B. W. Fox (Manchester, U.K.) briefly reviewed 
published work on the damage induced in mammalian 
cells by X-rays, U.V. light, alkylating agents and some 
chemical mutagens and carcinogens in an attempt to 
discover any characteristics of the timing of the 
repair processes following damage by these agents 
that could be related to their carcinogenic activity. 
Repair synthesis of DNA in P388F lymphoma cells 
was compared after exposure to methyl methanesul- 
phonate (MMS) and to N-methyl-N-nitrosourea 
(NMUrea). The time required for rejoining of single 
strand breaks was longer after MMS treatment than 
after X-ray or UV damage and repair after NMUrea 
treatment was even more protracted. It was suggested 
that this protracted repair synthesis following treat- 
ment with carcinogenic chemicals, with consequent 
attempted replication over damaged strands, might be 
a significant factor contributing to their carcinogenic 
effects. An efficient repair system might thus decrease 
the risk of carcinogenesis. 
JJ Roberts (London, U.K.) continued the discus- 
sion of DNA repair in carcinogenesis, mentioning 
repair deficient cells, as in Xeroderma; the possibility 
that CcFcarcinogens might act as inhibitors of repair; 
the possible consequences of faulty repair and the 
possibility that the repair process might release an 
integrated viral genome. Manifestations of excision 
repair of alkylated DNA can be demonstrated in 
mammalian cells in culture following treatment with 
alkylating agents. The amount of non-semiconservative 
synthesis is related to the extent of initial alkylation 
of cellular DNA and this “repair synthesis”, for which 
both purine and pyrimidine precursors can be used, 
continues for many hours after the initial alkylation. 
No difference was found in excision repair of DNA in 
Yoshida sarcoma cells which were sensitive or in- 
sensitive to cytotoxicity by alkylating agents, sug- 
gesting that a deficiency of this type of repair cannot 
be the basis of the difference in sensitivity. Similar 
results were obtained with HeLa cells which were 
sensitive or insensitive to N-methyl-N-nitrosourea. 
Evidence was presented that another form of repair, 
possibly related to post-replication repair, was 
responsible for these differences in sensitivity of cells 
to alkylating agents. This repair could be inhibited by 
caffeine. 
D. Bootsma (Rotterdam, The Netherlands) 
reviewed the defective DNA repair in Xeroderma 
pigmentosum cells in greater detail. Reduced repair 
DNA synthesis has been reported after treatment of 
xeroderma cells with 4-nitroquinoline l-oxide, 
4-hydroxyaminoquinoline l-oxide and N-acetoxy-Z 
acetylaminofluorene. In contrast, repair DNA synthe- 
sis following X-irradiation, methyl methanesulphonate 
or N-methyl-N’-nitro-N-nitrosoguanidine occurred at 
the normal level in xeroderma cells. The clinically 
distinct forms of Xeroderma pigmentosum (the classic 
form with skin lesions and the De Sanctis Cacchione 
form with neurological abnormalities in addition) 
might indicate the presence of different mutations ail 
resulting in U.V. sensitivity of the skin. The genetic 
heterogenicity of Xeroderma pigmentosum was 
studied by fusion of cells from different patients and 
measuring repair DNA synthesis in binucleate cells. 
Repair synthesis was found in cells derived from 
fusion between the De Sanctis Cacchione cell strains 
and the strains from classical forms of xeroderma but 
it was absent from the parental cells and from fusions 
between cells from different classic forms or different 
De Sanctis Cacchione patients indicating that two 
different genes are involved. It is possible that incom- 
plete repair might result in the presence of DNA lesions 
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at the time of DNA replication previous to cell division 
which might initiate mutagenesis and carcinogenesis. 
5. Possible inter-relations between chemical and 
viral carcinogenesis 
(Chairman: A.C. Allison, London, U.K.). L. Sachs 
(Rehovot, Israel) discussed his experiments on the 
chromosomal control of malignancy and the use of 
carbohydrate-binding lectins such as concanavalin A 
to elucidate the structure and activity of the cell 
surface membrane. His chromosome analysis of 
normal cells, cells transformed by viral or chemical 
carcinogens, and transformed cells that had been 
induced to revert to a normal phenotype, has led 
to the conclusion that viral and chemical carcinogens 
induce malignancy by inducing chromosome re- 
arrangements. Evidence was presented to show that 
these rearrangements produce a change in balance 
between chromosomally located factors that deter- 
mine expression and suppression of malignancy. His 
experiments with lectins have shown that changes in 
the structure and activity of the surface membrane 
that are required for a gain of agglutinability by 
concanavalin A are associated with cell malignancy 
in viva. These changes are not shown by the lectins 
from soybean and wheatgerm, and the same changes 
are found in cells transformed by chemical or viral 
carcinogens. 
R. Weiss (Los Angeles, Calif., USA) discussed 
the induction of RNA tumour viruses in normal cells 
by chemical carcinogens and mutagens. Avain 
tumour viruses were induced in normal embryonic 
chicken cells which were treated in culture with 
ionizing radiations or chemical carcinogens and 
mutagens. The induced viruses possess a buoyant 
density, DNA polymerase, polypeptides, and 70 S 
RNA typical of RNA tumour viruses. They act as 
“helper viruses” in complementing a strain of Rous 
sarcoma virus defective for replication and they 
undergo phenotypic mixing and genetic recombina- 
tion with other avian tumour viruses. The induced 
viruses belong to subgroup E as judged by host range, 
envelope antigens and interference patterns. These 
findings show that the induced viruses belong to 
the group known as avian RNA tumour viruses. How- 
ever, they do not transform fibroblasts and their 
oncogenic potential in uivo remains to be demon- 
strated. 
Nucleic acid hybridization studies suggest hat the 
viral genome exists in the normal cell in DNA form. 
Endogenous viral gene expression is under control of 
an autosomal locus with a dominant allele, gs+, for 
partial expression. When the gs+ allele is present, chick 
cells synthesize group-specific antigens of avian 
tumour viruses, complement certain defective 
mutants of Rous sarcoma virus and frequently 
become resistant to exogenous infection with viruses 
of the same subgroup specificity. 
In chicken cells lacking the gs+ allele, viral functions 
are activated in more than 50% cells by chemical 
carcinogens or mutagens, but less than 1 O-4 cells are 
induced to release infectious virus particles. 4-Nitro 
quinoline-l-oxide and 5Gododeoxyuridine appear to be 
the most effective inducing agents, though positive 
results were obtained with a variety of other agents. 
Recent studies on established lines of mouse cells 
show that they similarly possess endogenous viral 
genomes which can be activated by chemical mutagens. 
It is reasonable to speculate that all higher vertebrates 
possess endogenous viral information as suggested by 
Huebner and Todaro in their oncogene hypothesis. 
The relationship between chemical induction of RNA 
“tumour” viruses and chemical carcinogenesis is far 
from clear, but it would be unwise to ignore the 
presence of endogenous viral information in discussing 
mechanisms of carcinogenesis. 
6. Conclusion 
The meeting concluded with a wide-ranging dis- 
cussion, covering all the topics discussed, under the 
chairmanship of A.C. Allison (London, U.K.). 
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